TrialJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2023
Clinical Benefit From Immunotherapy in Patients With SCLC Is Associated With Tumor Capacity for Antigen Presentation.
Charles M Rudin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
65 papers cite itlatest 60 shown
this papertrialcites it